Sageworth Trust Company of South Dakota’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-281
Closed -$4K 408
2022
Q2
$4K Hold
281
0.01% 247
2022
Q1
$7K Sell
281
-1,248
-82% -$35.4K 0.01% 239
2021
Q4
$61K Buy
+1,529
New +$69.7K 0.09% 86

Other funds holding HCAT

Sageworth Trust Company of South Dakota's HCAT Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 281 shares — an estimated $4K sold.

Sageworth Trust Company of South Dakota first reported a position in HCAT in Q4 2021 and held it in 3 quarters. The position peaked at $61K in Q4 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 281 Health Catalyst shares in Q3 2022, an estimated $4K.
  • Sageworth Trust Company of South Dakota first reported a position in Health Catalyst in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Health Catalyst position peaked at $61K in Q4 2021.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.